All Activity

The Florida House of Representatives has passed a bill to significantly reduce the fee for military veterans to obtain medical marijuana registry identification cards. The measure from Reps. Susan Valdés (R) and Michelle Salzman (R) was approved in a unanimous 113-0 vote on Wednesday. This comes after the proposal cleared three House panels and as separate Senate legislation to reduce medical cannabis costs for veterans is also advancing. If HB 887 is enacted into law, veterans who have been honorably discharged would need to pay a $15 fee to obtain a medical cannabis card—down from the current $75 fee for most qualifying patients. The $15 charge would also apply to any replacement cards, as well as annual renewals. In order to qualify for the reduced fee, veterans would need to supply the state Department of Health (DOH) with a copy of their discharge release form, a U.S. Department of Veterans Affairs (VA) identification card or a Florida driver license “bearing the veteran designation.” The law would take effect beginning on July 1 of this year. “Medical cannabis has shown promise in alleviating symptoms commonly experienced by military veterans, like managing chronic pain, alleviating the effects of PTSD, improving sleep and reducing the dependency on opioids,” Valdés said on the House floor. “This bill will largely reduce the financial barriers veterans face when accessing medical marijuana, their chosen healthcare solution.” “By reducing the cost of access is not only a symbolic gesture for the veterans that serve us, it directly removes the cost barrier that’s too high often keeps already underserved veterans from participating in this program, and this is a way that we can show how grateful we are to our veterans by lighting that board green,” she said, as first reported by Florida Politics. According to a bill analysis, the reform would have an “indeterminate, negative fiscal impact on DOH.” While there are currently more than 931,000 registered medical marijuana patients in Florida, the “number of veterans who hold active medical marijuana use registry identification cards is unknown,” and so “the amount of revenue reduction is unknown.” That said, the analysis states that the policy change would “have a positive fiscal impact on veterans who will experience a $60 reduction in the cost of the identification card under the bill.” Earlier this month, the Senate Health Policy Committee advanced a bill from Sen. Alexis Calatayud (R) that would also reduce the medical cannabis registration fees for veterans to $15 and enact other reforms to expand medical marijuana access. Under that proposal as amended, a doctor would be able to recommend up to five 70-day supply limits of cannabis or up to 10 35-day supply limits of smokable marijuana products. Under current law, they can only provide recommendations for a maximum of three 70-day supply limits for non-smokable cannabis and six 35-day supply limits for smokable marijuana. The bill, SB 1032, would further make it so doctors would need to evaluate patients for medical marijuana qualification every 52 weeks, rather than the current statutory requirement of evaluations every 30 weeks. Here’s an overview of other pending Florida marijuana bills: A House lawmaker is sponsoring a bill to legalize recreational marijuana that also aims to break up what he calls “monopolies” in the state’s current medical cannabis program by revising the business licensing structure. Another representative’s bill would protect the parental rights of medical cannabis patients, preventing them from losing custody of their children for using their medicine in accordance with state law. Other legislation would also allow doctors to recommend cannabis to any patient who has a condition for which they have been prescribed opioids. A senator is sponsoring a bill to legalize home cultivation of marijuana for registered medical cannabis patients in the state. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a Florida campaign seeking to put marijuana legalization on the ballot is facing complications as it continues to litigate the status of its 2026 signature drive. Advocates are now asking the state Supreme Court to overturn officials’ decision to invalidate tens of thousands of petitions they submitted. A new poll released this week shows that a majority of Florida voters support legalizing cannabis. Photo courtesy of Max Jackson. The post Florida Lawmakers Pass Bill To Provide Discounted Medical Marijuana Cards For Military Veterans appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Hawaii senators have taken another step to advance a bill that would create a psychedelics task force responsible for studying and making policy recommendations on providing access to breakthrough therapies such as psilocybin and MDMA. About a week after the Senate Health and Human Services Committee unanimously approved the legislation from Sen. Chris Lee (D), members of the Ways & Means Committee followed suit on Tuesday, voting 12-0 to send the measure to the floor. The measure would create a Mental Health Emerging Therapies Task Force that’d be tasked with spending two years reviewing the current scientific literature, supporting additional clinical research and “developing policy recommendations for safe, ethical, and culturally-informed implementation” of a psychedelics therapy program. “The legislature finds that addressing the mental health crisis affecting the residents of the State, particularly among veterans, first responders, and trauma survivors, is urgent,” the bill, SB 3199, states. “Suicide continues to be a leading cause of preventable death, and the State must explore all safe and effective treatment options supported by scientific evidence.” Noting that the federal Food and Drug Administration (FDA) has already designated psilocybin and MDMA as breakthrough therapies in the treatment of serious mental health conditions, which could lend to future rescheduling under the Controlled Substances Act (CSA), the Hawaii legislation says the state “must proactively prepare public health, clinical, and research systems for safe and equitable implementation.” Members of the task force would have to include representatives of the state Department of Health (DOH), the attorney general’s office, the Office of Wellness and Resilience (OWR), the University of Hawaii’s medical school and more. As drafted, DOH would have overseen the task force, but that was amended in committee to make it the responsibility of “an entity with demonstrated expertise in primary scientific research and pharmaceutical or medical education.” “Administrative placement of the task force within an entity with demonstrated expertise in primary scientific research and pharmaceutical or medical education shall not be construed to transfer, delegate, diminish, expand, or otherwise modify any regulatory, enforcement, licensing, scheduling, or rulemaking authority vested in the Department of Health, Board of Pharmacy, or any other state agency,” the bill as revised says. “All statutory authority relating to controlled substances, professional licensure, and public health regulation shall remain with the appropriate executive branch agencies as provided by law.” It appears that the bill would build upon prior work conducted by a separate psychedelics task force that convened for the first time in 2023, with a similar goal of exploring pathways for therapeutic access into FDA-approved breakthrough drugs like psilocybin. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, Hawaii senators recently approved a bill to legalize low-dose and low-potency marijuana, even as their counterparts in the House of Representatives say cannabis prohibition will not be ended in the state this year. The Health and Human Services Committee also approved a bill to allow patients to immediately access medical cannabis once their registrations are submitted, instead of having to wait until their cards are delivered as is the case under current law. A separate marijuana legalization bill that contained provisions making the reform contingent on changes to federal law or the state Constitution, SB 2421, was deferred for action. Both Senate and House panels additionally deferred action on a measure to allow for the sale of certain hemp-derived cannabinoid products. The Senate committee action comes after key House lawmakers signaled that cannabis legalization proposals would not be advancing in the 2026 session, citing a lack of sufficient support in their chamber. Photo elements courtesy of carlosemmaskype and Apollo. The post Hawaii Senators Advance Bill To Create Psychedelics Task Force And Study Pathways To Access Psilocybin And MDMA appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Virginia lawmakers are nearing the finish line for a series of marijuana reform bills—including proposals to legalize adult-use sales, provide a pathway for resentencing past convictions and allow patients to use medical cannabis in hospitals. The House on Wednesday approved a Senate-passed measure, SB 542 from Sen. Lashrecse Aird (D), to establish a commercial marijuana market in a 66-33 vote, with amendments to more closely conform it to the House’s own measure. And the Senate cleared that House companion version, HB 642 from Del. Paul Krizek (D), in a 21-19 vote after adopting amendments to conform it to the body’s version. “As we get this bill into conference, Senator Aird and I will continue our work to get this bill to the best posture to ensure Virginia consumers have access to a safe, regulated and taxed product, with public safety at the forefront,” Krizek said ahead of the House vote. Also on the House side, the chamber on Wednesday voted 65-34 to approve an amended version of legislation sponsored by Sen. Louise Lucas (D), SB 62, to give relief to people with prior cannabis-related convictions. Both chambers’ marijuana sales proposals have been aimed at giving adults a legal means of buying cannabis, the possession and home cultivation of which was legalized in the state in 2021—though there are key differences that remain, including with respect to the start date for legal sales and tax rates. Bicameral lawmakers have made progress aligning on other details in recent weeks, however. For example, both bills were amended to stipulate that microbusiness licensees can cultivate, process or conduct retail sales at up to two locations instead of one, so long as they’re located within 10 miles of each other and operate under common ownership and control. Lawmakers have also revised the legislation to clarify that current medical cannabis businesses would only be able to cultivate cannabis indoors, including in secure greenhouses with a total canopy cap of 70,000 square feet. The amendments also make it so they could not have any additional marijuana licenses beyond their medical permits with “dual-use privileges.” Finally, the measures’ conversion fee structure was revised in a way that lets current medical marijuana businesses pay for the privilege to serve the adult-use market in three installments. With respect to the Senate marijuana sales bill, members recently clashed in committee about amendments to the body’s version that would have added new penalties for illegal cannabis activity. The amendments at issue from the Courts of Justice Committee included penalties for consumers who buy from unlicensed sources, the recriminalization of cannabis possession by people under 21 and making sales a class 1 misdemeanor for a first offense and a crime punishable by mandatory jail time for a second offense. As revised, the bill would have also raised the penalty for unlicensed cultivation to a felony punishable by up to five years in jail and made it a felony to transport with intent to distribute cannabis across state lines. But the Finance and Appropriations Committee reversed the amendments last month amid pressure from a coalition of advocacy groups that sent a letter to senators saying they undermined the “intent” of the legislation and the “will of the people” by adding criminal penalties for certain cannabis-related activity. Here are the key details of the Virginia marijuana sales legalization legislation, SB 542 and HB 642: Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. The House bill sets the state date for legal sales as November 1, 2026, while the Senate measure would allow them to begin on January 1, 2027. The Senate bill would set an excise tax on cannabis products of 12.875 percent, in addition to a 1.125 percent state sales tax and a mandatory 3 percent local tax. The House measure would apply an excise tax of 6 percent as well as a 5.3 percent retail sales and use tax, while allowing municipalities to set a local tax of up to 3.5 percent. Under the House bill, the Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, while the Senate legislation tasks that to a new combined Alcoholic Beverage and Cannabis Control Authority. The House bill calls for revenue to be distributed to a new Cannabis Equity Reinvestment Fund (60 percent), early childhood education (10 percent), the Department of Behavioral & Developmental Health Services (25 percent) and public health initiatives (5 percent). The Senate proposal, meanwhile, would put 30 percent toward the equity reinvestment fund, 40 percent for early childhood eduction, 25 percent to the behavioral and developmental health services department and 5 percent to public health initiatives. Local governments could not opt out of allowing marijuana businesses to operate in their area. Delivery services would be allowed. Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. Existing medical cannabis operators could enter the adult-use market if they pay a licensing conversion fee that is set at $15 million in the Senate bill and $10 million in the House measure. Cannabis businesses would have to establish labor peace agreements with workers. A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. It would also investigate the possibility of the Virginia Alcoholic Beverage Control Authority becoming involved in marijuana regulations and enforcement. Overall, both chambers’ commercial sales bills have largely aligned with recommendations released in December by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. Meanwhile, certain GOP members have found themselves ideologically aligned with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus in support of creating a regulated marketplace for adults to purchase cannabis. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under former Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. Gov. Abigail Spanberger (D), for her part, supports legalizing adult-use marijuana sales. Meanwhile, Virginia House and Senate lawmakers have been advancing a pair of companion bills that would provide a pathway to resentencing for people with prior marijuana convictions. The House voted 65-34 on Wednesday to pass Lucas’s version, The legislation as introduced in both chambers would create a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana could receive an automatic hearing to consider modification of their sentences. Separately Virginia lawmakers this week took additional steps toward enacting legislation that would let certain patients use medical marijuana in hospitals, teeing up the reform to be sent to the governor’s desk imminently. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, Virginia lawmakers are also advancing a bill to protect the rights of parents who use marijuana in compliance with state law. Under the proposal from Del. Nadarius Clark (D), possession of use of cannabis by a parent or guardian on its own “shall not serve as a basis to deem a child abused or neglected unless other facts establish that such possession or consumption causes or creates a risk of physical or mental injury to the child.” “A person’s legal possession or consumption of substances authorized under [the state’s marijuana law] alone shall not serve as a basis to restrict custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” the text of the bill, HB 942, states. Separately, the Virginia Department of Labor and Industry recently published a new outlining workplace protections for cannabis consumers. Photo courtesy of Mike Latimer. The post Virginia Marijuana Bills Near Finish Line With Votes On Legalizing Sales And Resentencing Prior Convictions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

As Florida officials defend their decision to invalidate tens of thousands of signatures for a proposed marijuana legalization ballot initiative, a new poll reaffirms that a majority of Floridians want to see the reform enacted. The Smart & Safe Florida campaign behind the cannabis initiative has found itself fighting in multiple court cases in hopes of giving voters another chance to decide on legalization. That currently involves a case challenging state officials over the invalidation of signatures from inactive voters and those collected by non-residents. While the signature count was recently reset to zero by the state Division of Elections, the marijuana campaign hasn’t abandoned the lawsuit, urging the state Supreme Court to intervene. And on Monday, the division and secretary of state’s office submitted a brief urging the justices to deny Smart & Safe Florida’s motion for a discretionary review into the controversy. “Discretionary review is unwarranted,” the officials said in the brief, which was first reported by Law360. “First, the First District’s opinion does not meet any of the criteria for discretionary jurisdiction in Article V, Section 3(b)(3) of the Florida Constitution. Second, the decision below is plainly correct: the Secretary has statutory authority to provide written direction to the Supervisors, and the circuit court’s declarations about the Directives’ legal conclusions constituted impermissible advisory opinions. Third, because Smart & Safe missed the [February 1] deadline for qualifying its petition for the ballot and the disputed signatures have expired, this case is moot.” As the state fights the legal challenge from the cannabis campaign, which has also faced opposition from Gov. Ron DeSantis (R), a newly released survey from the University of North Florida’s Public Opinion Research Lab (PORL) strongly signals that the state it out of step with most residents in the state. The poll found that 66 percent of likely midterm voters in Florida are in favor of legalizing marijuana for adult use, compared to 30 percent who said they oppose the reform. Consistent with past polling on the issue, support was strongest among Democrats (77 percent) and independents (80 percent). But even a slim majority of Republicans (50 percent) back the policy change. “Just as we found throughout much of 2024, marijuana legalization enjoys high cross-partisan support,” Sean Freeder, PORL director and a professor of political science, said in a press release. “However, once Gov. DeSantis began heavily campaigning against the amendment, support soured enough to lead to its failure. This could happen again, though we won’t find out in 2026, given enough signatures were rejected in legal challenges to keep the issue off the ballot.” The survey involved interviews with 786 likely Florida midterm voters from February 21-March 2. Meanwhile, the lawsuit over signatures from inactive voters and those gathered by non-residents came after another court upheld a previous decision to strike about 200,000 signatures that the state said were invalid because the petitions didn’t include the full text of the proposed initiative. The campaign contested the legal interpretation, but it declined to appeal the decision based on their confidence they’d collected enough signatures to make up the difference. Smart & Safe Florida has generally disputed the secretary of state’s signature count, asserting the campaign submitted over 1.4 million petitions—hundreds of thousands more than the 880,062 valid signatures required to go before voters. In a recent filing with the Supreme Court, Attorney General James Uthmeier (R) said his office was withdrawing its earlier request for a legal review in the constitutionality of the proposed cannabis initiative because the state claimed the campaign submitted an insufficient number of signed petitions. The last count, according to the secretary of state’s office, was 783,592 validated signatures. In its reply brief, Smart & Safe Florida said the secretary of state’s office made a determination that the campaign didn’t satisfy requirements for ballot placement based on a “conclusion that the Sponsor failed to meet the requisite signature threshold in light of the invalidations that the Sponsor is contesting.” Ahead of the signature turn-in, Florida’s attorney general and several business and anti-marijuana groups urged the state Supreme Court to block the cannabis initiative, calling it “fatally flawed” and unconstitutional. The Florida Chamber of Commerce, Florida Legal Foundation and Judge Frank Shepherd filed a separate joint brief stating that the parties remain “especially vigilant about the abuse of the citizen initiative process by out-of-state interests that think of Florida as just another market and the citizen initiative process as just another means of exploiting that market.” The Florida Chamber of Commerce has consistently opposed attempts to move forward with adult-use legalization, even as its own polling has shown majority support for the reform. In January, the state attorney general’s office opened dozens of criminal investigations and submitted subpoenas requesting records from Smart & Safe Florida and its contractors and subcontractors over alleged fraud related to the petitioning effort. Activists said in November that they’d collected more than one million signatures to put the cannabis measure on the ballot, but it’s also challenged officials at the state Supreme Court level over delays the certification process, arguing that the review of the ballot content and summary should have moving forward months ago when it reached an initial signature threshold. The state then agreed to move forward with the processing. The governor campaigned heavily against an earlier version of the legalization proposal, which received a majority of voters in 2024 but not enough to meet the 60 percent threshold required to pass a constitutional amendment. Former Attorney General Ashley Moody (R) unsuccessfully contested the prior initiative in the courts. Last March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to DeSantis. The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. The lawmakers’ letter followed allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing Amendment 3. The governor said last February that the newest marijuana legalization measure is in “big time trouble” with the state Supreme Court, predicting it would be blocked from going before voters this year. “There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.” “But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said. The latest initiative was filed with the secretary of state’s office just months after the initial version failed during the November 2024 election—despite an endorsement from President Donald Trump. Smart & Safe Florida expressed optimism that the revised version would succeed in 2026. The campaign—which in the last election cycle received tens of millions of dollars from cannabis industry stakeholders, principally the multi-state operator Trulieve—incorporated certain changes into the new version that seem responsive to criticism opponents raised during the 2024 push. For example, it now specifically states that the “smoking and vaping of marijuana in any public place is prohibited.”Another section asserts that the legislature would need to approve rules dealing with the “regulation of the time, place, and manner of the public consumption of marijuana.” In 2023, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released last February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, last month, Florida senators approved an amended bill to increase the amount of medical marijuana a registered patient can buy and slash the fee for medical cannabis identification cards for military veterans. The vote came after the Senate Regulated Industries Committee passed separate legislation to ban smoking or vaping marijuana in public places. Rep. Alex Andrade (R) is sponsoring a similar bill to ban public cannabis smoking in the House, and that recently moved through committee. The post Florida Voters Support Marijuana Legalization, New Poll Shows As State Officials Defend Invalidation Of Ballot Signatures appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Washington State Senate lawmakers have sent the governor a bill to allow terminally ill patients to use medical cannabis in healthcare facilities such as hospitals, nursing homes and hospices. The legislation, sponsored by Rep. Shelley Kloba (D), was passed by the Senate in a 46-2 vote on Tuesday after having previously been passed by the full House of Representatives in a vote of 89-6 last month. It next heads to the desk of Gov. Bob Ferguson (D). If enacted in to law, the legislation would mandate that hospitals and other specified healthcare facilities allow terminally ill patients to use medical marijuana on the premises beginning on January 1, 2027, subject to certain rules and restrictions. “The medical use of cannabis may support improved quality of life for a qualifying patient…with a terminal condition,” the bill’s text says. “It is the intent of the legislature to promote dignity and comfort for terminally ill patients while maintaining the integrity and safety of health care environments.” Sen. Annette Cleveland (D) said on the Senate floor ahead of the vote that the bill “truly can improve quality of life for patients as they face their final days.” Under HB 2152, patients and their caregivers would be responsible for acquiring and administering medical marijuana, and it would need to be stored securely at all times in a locked container. Smoking or vaping of cannabis would be prohibited, so patients would need to consume it via other methods. Marijuana could not be shared between patients and visitors, and the right to use medical cannabis under the bill would not apply to patients who are in the emergency department. Healthcare facility officials would need to see a copy of patients’ authorization to use medical cannabis, and they would be required to note their use of the drug in medical records. They would also need to establish a formal policy “allowing for the medical use of cannabis” on the premises. Facilities would also be able to suspend permission to use cannabis under the bill if a federal agency such as the U.S. Department of Justice or Centers for Medicare and Medicaid Services takes an enforcement action against such use or “issues a rule or other notification that expressly prohibits the medical use of cannabis in health care facilities.” The House Health Care & Wellness Committee adopted an amendment to exempt nursing homes operated by a residential habilitation center from the requirement to allow the medical use of cannabis, to clarify that the bill doesn’t apply to patients who haven’t been formally admitted to a hospital and to specify that patients and their caregivers are responsible for retrieving the medical cannabis (in addition to their responsibilities related to acquiring, administering, and removing the medical cannabis). California and a handful of other states already have laws allowing terminally ill patients to use medical cannabis in healthcare facilities. Known as “Ryan’s Law,” the legislation is partly inspired by the experience of Jim Bartell, whose son died from cancer and was initially denied access to cannabis at a California hospital. The Bartells did eventually find a facility that agreed to allow the treatment, and Jim said Ryan’s quality of life improved dramatically in his final days. Sen. Marcus Riccelli (D) on Tuesday spoke about Ryan’s story on the Senate floor. “He was given fentanyl, which made him basically unable to communicate with his family,” the senator said. “He was able to be moved to a hospital where medical cannabis was used. He was lucid and really got a lot out of the last few weeks of his life. And so the goal here is to provide more opportunities for that for more people.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Lawmakers in several other states are also considering and advancing bills to expand medical marijuana access in hospitals, nursing homes and hospices. Meanwhile, Washington State lawmakers this session also filed a bill to legalize the home cultivation of marijuana for personal use by adults. Separate legislation was also introduced to allow short-term rentals like Airbnbs in Washington State would be able to offer guests complimentary marijuana prerolls. Yet another measure that was filed would legalize and regulate therapeutic use of the psychedelic psilocybin. Photo courtesy of Max Pixel. The post Washington Bill To Allow Medical Marijuana Use In Hospitals Heads To Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Michigan officials have announced they are distributing nearly $100 million in marijuana tax revenue to over 300 local governments and tribes across the state thanks to the state’s adult-use legalization law. The $94 million in tax dollars will support various local infrastructure, education and other programs and services in 313 municipalities, counties and tribal areas. That level of cannabis-derived funding is roughly equivalent to what the state allocated last year. “A total of 114 cities, 39 villages, 81 townships, 75 counties, and four tribes will receive payments from the Marijuana Regulation Fund,” officials with the state Cannabis Regulatory Agency (CRA) said in a press release on Tuesday. “For the State of Michigan’s 2025 fiscal year, this means each eligible municipality, county, and tribe will receive $54,017.10 for every licensed retail store and microbusiness located within its jurisdiction,” the agency said. Under the state’s cannabis law, tax dollars from marijuana sales must go to cities and tribes with licensed retailers (15 percent), counties and tribes with retailers (15 percent), the School Aid Fund for K-12 eduction (35 percent) and the Michigan Transportation Fund for repairs and maintenance of roads and bridges (35 percent). The announcement from state cannabis regulators comes amid a contentious battle over a take hike on wholesale marijuana products that was implemented last year and has since faced legal challenges from marijuana businesses in the state. A Michigan court in January denied the state’s request to toss the lawsuit, which targets the 24 percent wholesale tax that’s been embraced by certain state Democratic senators and Gov. Gretchen Whitmer (D). Recently filed legislation seeks to repeal the new tax. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Michigan reached a marijuana sales milestone in 2024, with over $10 billion in adult-use cannabis products sold that year. State officials said in late 2023 that tax revenue from legal marijuana grew by 49 percent compared to 2022, surpassing the amount of revenue made from alcohol sales. Marijuana sales incur a 10 percent excise tax—among the lowest rates in the nation—as well as a 6 percent state sales tax. Meanwhile, Michigan legislators this session are looking into a proposal to create a statewide marijuana reference laboratory that would help standardize testing facilities to ensure quality control for cannabis products. Photo courtesy of Chris Wallis // Side Pocket Images. The post Michigan Officials Are Sending Nearly $100 Million In Marijuana Tax Money To Local Government And Tribes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Virginia lawmakers have taken more steps toward enacting legislation that would let certain patients use medical marijuana in hospitals, teeing up the reform to be sent to the governor’s desk imminently. On Monday, the Senate signed off on the House of Delegates’s changes to SB 332, sponsored by from Sen. Barbara Favola (D), and the presiding officers of both chambers formally signed the bicameral agreement. It will next head to Gov. Abigail Spanberger (D) to be signed, vetoed or sent back with suggested amendments—but first a companion House bill from Del. Karen Keys-Gamarra (D), HB 75, needs to have a procedural error corrected in order to accompany the Senate proposal. The legislation would build upon existing state law protecting health professionals at hospices, nursing homes and assisted living facilities that aid terminally ill patients in utilizing medical cannabis treatment from punishment by adding hospitals to the statute. It would also create a new working group under the Department of Health to “discuss the implementation process for providing cannabis products to patients within medical care facilities.” “The work group shall assess any available federal guidance or proposed regulations on the use of cannabis products or changes to the schedule for cannabis products under the federal Controlled Substances Act (21 U.S.C. § 801 et seq.) as well as interaction with applicable state laws,” the bill says. Its members would include representatives of the Virginia Hospital & Health Care Association and the Virginia Health Care Association, as well as health care providers and palliative, hospice, and hospital volunteers familiar with issues associated with providing care to individuals experiencing chronic illness. The legislation directs the working group to submit a report to key legislative committees including “written guidelines for the use of medical cannabis within medical care facilities and the safe operations of medical care facilities” by November 1. As originally introduced, the Senate measure would have simply directed the state the Department of Health to form a working group to explore the reform, but its scope was expanded in an earlier subcommittee hearing. “Cannabis oil has been effective in ameliorating some severe pain and also helping with nausea and appetite loss,” Favola, the sponsor, said ahead of a Senate vote last month. SB 332 “has a couple guardrails in it, and we’re merely trying to treat patients in hospitals and give them the same options as we’ve currently giving patients in nursing homes and in hospice.” The Senate also approved a substitute version of a House bill on the issue on Monday, but its text was mistakenly replaced with an earlier iteration that would add hospitals to the current medical cannabis law but only “upon the date that marijuana is federally rescheduled from Schedule I to Schedule III under the federal Controlled Substances Act.” That wasn’t supposed to be the plan, however, and the expectation is that the House will reject the revised HB 75 as passed by the Senate and go to bicameral conference where members will make it identical to the Senate bill that’s now been approved in both chambers, with both then heading to the governor’s office together. Meanwhile, the march toward legalizing recreational marijuana sales in Virginia also continues on, with the full House and a Senate committee advancing a pair of companion bills to create a regulated adult-use cannabis market in the Commonwealth. Overall, both chambers’ commercial sales bills have largely aligned with recommendations released in December by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. Certain GOP members have found themselves ideologically aligned with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus in support of creating a regulated marketplace for adults to purchase cannabis. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under former Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. Gov. Abigail Spanberger (D), for her part, supports legalizing adult-use marijuana sales. The Virginia legislature took action on multiple marijuana bills on a key deadline last month—passing proposals to legalize cannabis sales, provide a pathway to resentencing for prior marijuana convictions and allow medical cannabis access in hospitals for seriously ill patients. Lawmakers in both chambers on Monday advanced a pair of companion bills, with amendments, that would provide a pathway to resentencing for people with prior marijuana convictions. Members of the Senate and House Courts of Justice Committees on Monday approved substitute versions of the opposite chamber’s reform legislation, making certain revisions that set the stage for bicameral negotiations as the measures move forward in the legislative process. The legislation as introduced in both chambers would create a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana could receive an automatic hearing to consider modification of their sentences. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the Virginia House this month approved a bill to protect the rights of parents who use marijuana in compliance with state law. Under the proposal from Del. Nadarius Clark (D), possession of use of cannabis by a parent or guardian on its own “shall not serve as a basis to deem a child abused or neglected unless other facts establish that such possession or consumption causes or creates a risk of physical or mental injury to the child.” “A person’s legal possession or consumption of substances authorized under [the state’s marijuana law] alone shall not serve as a basis to restrict custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” the text of the bill, HB 942, states. Separately, the Virginia Department of Labor and Industry recently published a new outlining workplace protections for cannabis consumers. The post Virginia Legislation To Let Patients Use Medical Marijuana In Hospitals Set For Governor’s Decision appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This topic is more relevant now than ever. www.sidingcontractorvictoriabc.com/soffits-fascia-service-victoria

Texas voters have approved a marijuana legalization question that appeared on the state’s Democratic primary ballot. As part of the primary election on Tuesday, each major party was able to place several non-binding propositions on the ballot that allow voters show how they feel on key issues. The Texas Democratic Party used one of its propositions to find out where the electorate stands on legalizing cannabis and whether past convictions should be expunged. Preliminary results indicate that Texas voters who selected a Democratic primary ballot approved the cannabis question by a margin of 80 percent to 20 percent, with 85 percent of polling locations reporting as of Wednesday morning. The yes or no question on Democratic primary ballots read: “Texas should legalize cannabis for adults and automatically expunge criminal records for past low-level cannabis offenses.” There was no cannabis question on the Republican ballot, but Texas has an open primary system in which voters can opt to participate in either party’s primary regardless of how they are registered. The approval of Democrats’ marijuana question will not on its own change any cannabis laws, but it could send a signal to lawmakers that the reform is popular with voters. For what it’s worth, a statewide poll released last month found that Texas voters don’t like how state leaders and lawmakers have handled marijuana and THC policy issues. In the survey, a plurality of voters (40 percent) said they disapprove of how their elected officials have approached the issue, according to the survey. Just 29 percent said they approve of how cannabis issues have been handled, while 31 percent said they didn’t have an opinion one way or another. A separate poll released last year found that a plurality of Texas voters want the state’s marijuana laws to be made “less strict.” And among the legislative items lawmakers considered during recent special sessions, voters say a proposal to address hemp regulations was among the least important. In the background, officials with the Department of Public Safety (DPS) in December conditionally approved nine new medical marijuana business licenses in December as part of a law that’s being implemented to significantly expand the state’s cannabis program. The department will issue conditional licenses to three additional dispensaries by April 2026. This represents a major change to the program, as there are currently only three dispensaries licensed to operate in Texas. DPS in October adopted additional rules to increase the number of licensed dispensaries, establishing security requirements for “satellite” locations and authorizing the revocation of licenses for certain violations. The Department of State Health Services (DSHS) also recently finalized rules allowing doctors to recommend new qualifying conditions for cannabis patients and creating standards for allowable low-THC inhalation devices. Meanwhile, bipartisan Texas lawmakers say the stage is set to advance legislation next session establishing regulations for hemp THC products, with growing understanding among their colleagues that prohibition fails to effectively address concerns about the cannabis market. In the interim, Texas regulators have taken a series of steps to enact rules around consumable hemp products over recent months, which began after Gov. Greg Abbott (R) vetoed a bill last year that would’ve effectively eradicated the state’s hemp market. In late December, meanwhile, the Department of State Health Services (DSHS) released a set of proposed rules to regulate the state’s hemp market—including provisions related to age-gating, licensing fees, testing requirements, packaging restrictions and more in response to an executive order the governor signed in September. Image element courtesy of AnonMoos. The post Texas Voters Approve Marijuana Legalization Ballot Measure appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The item senses brilliant to learn to read like beneficial in addition to one of a kind articles or blog posts with your internet websites. https://iptvpremium.pt/

WI gov pushes Congress on hemp; VA marijuana sales bills advance; CT psychedelics; WA medical cannabis in hospitals Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Wisconsin Gov. Tony Evers (D) sent a letter urging the state’s congressional delegation to work to prevent the federal recriminalization of hemp THC products, saying the need for action is “further intensified by the fact that Wisconsin has not enacted legislation legalizing medical or recreational marijuana, despite multiple attempts by my administration to do so.” A poll of Massachusetts residents found that they overwhelmingly oppose a proposed ballot initiative to roll back the state’s marijuana legalization law, 63 percent to 20 percent. The Virginia House of Delegates and Senate Finance & Appropriations Committee approved bills to legalize recreational marijuana sales, moving the chambers closer to negotiations on a final version to send to Gov. Abigail Spanberger (D). The Washington State Senate Ways & Means Committee approved a bill to allow terminally ill patients to use medical cannabis in healthcare facilities such as hospitals, nursing homes and hospices. The Connecticut legislature’s Joint Committee on Public Health approved a bill to expand the state’s psychedelics pilot program to allow all adults who meet clinical eligibility criteria can participate, instead of just veterans, retired first responders and direct care health care workers. Gennaro Luce and Matthew Myro Rothman of CannaLnx argue in a new Marijuana Moment op-ed that rescheduling won’t stabilize the industry unless it is accompanied by “clear federal guidance on reimbursement pathways, claims administration and benefit integration” for medical cannabis. / FEDERAL A former Department of Justice Office of Justice Programs and the Office of Legal Policy official authored an op-ed about a case before the Supreme Court on cannabis consumers’ gun rights. House Foreign Affairs Committee Democrats criticized President Donald Trump for pardoning former Honduran President Juan Orlando Hernández for drug charges while at the same time conducting deadly military strikes on suspected drug boats. The Food and Drug Administration Division of Applied Regulatory Science noted some of its cannabis research projects in an annual report. / STATES The Wisconsin Legislative Black Caucus included cannabis legalization in its policy agenda. Alaska lawmakers are considering legislation to revise marijuana taxes. Vermont regulators took action on hemp-derived ingredients, product formulation requirements, labeling standards and packaging waivers. Missouri regulators published guidance on infused marijuana prerolls and infused flower. Ohio regulators published guidance on cannabis weekly inventory report requirements. Washington State published guidance on cannabis transport manifests. The California Legislative Analyst’s Office published an update on cannabis tax revenue. Michigan regulators filed a complaint against a marijuana business over alleged violations. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Mexican President Claudia Sheinbaum said her country is not waging a “war on drugs” even as it ramps up military operations against cartels. / SCIENCE & HEALTH A review concluded that “CBD engages the endocannabinoid system (ECS) and related receptors to preserve epithelial barrier integrity, regulate gut microbiota composition, and modulate intestinal oxidative stress and inflammation.” A study found that “mystical experiences – particularly experiences of unity, sacredness, and transcendence – during psilocybin sessions are associated with greater [obsessive-compulsive disorder] symptom reduction.” / ADVOCACY, OPINION & ANALYSIS Prohibitionist organization Smart Approaches to Marijuana launched an ad campaign urging Virginia lawmakers not to legalize recreational marijuana sales. / BUSINESS Verdant Partners is acquiring the retail operations of Native Roots. PAX released a newly redesigned cannabis dry herb vaporizer. / CULTURE Ethan Hawke spoke about how his first acting award he ever won was a bong from High Times. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Max Jackson. The post Anti-cannabis ballot measure lacks support in Massachusetts, poll shows (Newsletter: March 4, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

To qualify for the welcome free bet offer, you must first create an account using the 1X200GIFT promo code, then make a minimum deposit of $30 and place your first bet using your own funds. The system will then unlock the free bet. However, to withdraw any winnings obtained using the free bet, you need to meet the wagering requirements specified by the promotion. Typically, this involves betting the full bonus amount on selections with odds of at least 1.50. If your bet wins, you will be able to withdraw the profit — excluding the free bet amount itself. how to use promo code on 1xbet

Its a great pleasure reading your post.Its full of information I am looking for and I love to post a comment that "The content of your post is awesome" Great work. วิธีสมัครสมาชิก ufabet123

The march toward legalizing recreational marijuana sales in Virginia continues on, with the full House of Delegates and a Senate committee advancing a pair of companion bills to create a regulated adult-use cannabis market in the Commonwealth. The House on Tuesday passed a Senate-approved cannabis sales bill on second reading, teeing it up for final passage in the chamber. Earlier in the day, a House companion measure moved through the Senate Finance and Appropriations Committee in a 10-5 vote, sending the measure to the floor for consideration. Both chambers’ marijuana sales proposals are aimed at giving adults a legal means of buying cannabis, the possession and home cultivation of which was legalized in the state in 2021—though there are key differences between them. The measures in both chambers—HB 642 and SB 542—were recently amended to stipulate that microbusiness licensees can cultivate, process or conduct retail sales at up to two locations instead of one, so long as they’re located within 10 miles of each other and operate under common ownership and control. Lawmakers have also revised the legislation to clarify that current medical cannabis businesses would only be able to cultivate cannabis indoors, including in secure greenhouses with a total canopy cap of 70,000 square feet. The amendments also make it so they could not have any additional marijuana licenses beyond their medical permits with “dual-use privileges.” Finally, the measures’ conversion fee structure was revised in a way that lets current medical marijuana businesses pay for the privilege to serve the adult-use market in three installments. There are certain remaining major differences between the chambers’ bills that will still need to be addressed—related to the start date for legal sales and cannabis tax rates—before a final product can be delivered to the governor’s desk. Here are the key details of the Virginia marijuana sales legalization legislation, SB 542 and HB 642: Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. The House bill sets the state date for legal sales as November 1, 2026, while the Senate measure would allow them to begin on January 1, 2027. The Senate bill would set an excise tax on cannabis products of 12.875 percent, in addition to a 1.125 percent state sales tax and a mandatory 3 percent local tax. The House measure would apply an excise tax of 6 percent as well as a 5.3 percent retail sales and use tax, while allowing municipalities to set a local tax of up to 3.5 percent. Under the House bill, the Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, while the Senate legislation tasks that to a new combined Alcoholic Beverage and Cannabis Control Authority. The House bill calls for revenue to be distributed to a new Cannabis Equity Reinvestment Fund (60 percent), early childhood education (10 percent), the Department of Behavioral & Developmental Health Services (25 percent) and public health initiatives (5 percent). The Senate proposal, meanwhile, would put 30 percent toward the equity reinvestment fund, 40 percent for early childhood eduction, 25 percent to the behavioral and developmental health services department and 5 percent to public health initiatives. Local governments could not opt out of allowing marijuana businesses to operate in their area. Delivery services would be allowed. Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. Existing medical cannabis operators could enter the adult-use market if they pay a licensing conversion fee that is set at $15 million in the Senate bill and $10 million in the House measure. Cannabis businesses would have to establish labor peace agreements with workers. A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. It would also investigate the possibility of the Virginia Alcoholic Beverage Control Authority becoming involved in marijuana regulations and enforcement. The Virginia House and Senate both took action on multiple marijuana bills on a key deadline last month—passing proposals to legalize cannabis sales, provide a pathway to resentencing for prior marijuana convictions and allow medical cannabis access in hospitals for seriously ill patients. With respect to the Senate marijuana sales bill, members recently clashed in committee about amendments to the body’s version that would have added new penalties for illegal cannabis activity. The amendments at issue from the Courts of Justice Committee included penalties for consumers who buy from unlicensed sources, the recriminalization of cannabis possession by people under 21 and making sales a class 1 misdemeanor for a first offense and a crime punishable by mandatory jail time for a second offense. As revised, the bill would have also raised the penalty for unlicensed cultivation to a felony punishable by up to five years in jail and made it a felony to transport with intent to distribute cannabis across state lines. But the Finance and Appropriations Committee reversed the amendments last month amid pressure from a coalition of advocacy groups that sent a letter to senators saying they undermined the “intent” of the legislation and the “will of the people” by adding criminal penalties for certain cannabis-related activity. Overall, both chambers’ commercial sales bills have largely aligned with recommendations released in December by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. Meanwhile, certain GOP members have found themselves ideologically aligned with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus in support of creating a regulated marketplace for adults to purchase cannabis. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under former Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. Gov. Abigail Spanberger (D), for her part, supports legalizing adult-use marijuana sales. Meanwhile, Virginia House and Senate lawmakers on Monday advanced a pair of companion bills, with amendments, that would provide a pathway to resentencing for people with prior marijuana convictions. Members of the Senate and House Courts of Justice Committees on Monday approved substitute versions of the opposite chamber’s reform legislation, making certain revisions that set the stage for bicameral negotiations as the measures move forward in the legislative process. The legislation as introduced in both chambers would create a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana could receive an automatic hearing to consider modification of their sentences. Separately last month, the Virginia House passed a bill to allow patients to use medical marijuana in hospitals. It would require healthcare facilities to establish policies “to address circumstances under which an eligible patient would be permitted to use medical cannabis.” The Senate passed differing legislation concerning the use of medical cannabis in health care facilities last month. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the Virginia House this month approved a bill to protect the rights of parents who use marijuana in compliance with state law. Under the proposal from Del. Nadarius Clark (D), possession of use of cannabis by a parent or guardian on its own “shall not serve as a basis to deem a child abused or neglected unless other facts establish that such possession or consumption causes or creates a risk of physical or mental injury to the child.” “A person’s legal possession or consumption of substances authorized under [the state’s marijuana law] alone shall not serve as a basis to restrict custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” the text of the bill, HB 942, states. Separately, the Virginia Department of Labor and Industry recently published a new outlining workplace protections for cannabis consumers. Photo courtesy of Chris Wallis // Side Pocket Images. The post Virginia House And Senate Lawmakers Advance Marijuana Sales Legalization Bills Toward Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“A stable cannabis industry requires more than tax normalization. It requires integration into healthcare infrastructure that governs how therapeutic products are accessed, financed and sustained.” By Gennaro Luce and Matthew Myro Rothman, CannaLnx Momentum around federal cannabis reform has shifted. Following President Donald Trump’s executive order directing the rescheduling of cannabis, investors have interpreted the move as a meaningful step toward normalization. Multistate operators are accelerating acquisitions. Capital markets are cautiously reengaging. Optimism is back in the headlines. Rescheduling would be significant. But it will not, by itself, stabilize the cannabis industry. Moving cannabis from Schedule I to Schedule III would ease one of the most punishing structural burdens operators face: Section 280E of the Internal Revenue Code. Relief from 280E would improve margins, unlock cash flow and potentially make the sector more attractive to institutional investors. That is not trivial. But 280E reform addresses taxation. It does not address integration or infrastructure. The cannabis industry’s deeper instability is not simply a tax problem. It is a structural demand problem rooted in the fact that cannabis remains overwhelmingly an out-of-pocket purchase—even when used for medical purposes. Rescheduling does not automatically create reimbursement pathways. It does not authorize or compel Medicare, Medicaid or commercial insurers to recognize cannabis as a covered therapeutic. It does not establish billing codes, claims infrastructure, validation mechanisms or federal guidance for employer-sponsored health plans. And it does not change the reality that most medical cannabis patients today must pay entirely out of pocket. As long as cannabis remains a cash-based retail product, its market dynamics will resemble consumer discretionary goods—not health care. That distinction matters. Out-of-pocket markets are inherently price-sensitive. They are vulnerable to discounting cycles, promotional churn, pricing inconsistency, lack of standards and illicit market competition. Patient retention is fragile when therapy depends on weekly or monthly cash flow rather than structured and reliable benefit coverage. In that environment, consolidation may create larger operators. But it does not foster durable demand. Recent M&A activity reflects renewed confidence following rescheduling signals. But consolidation in a cash-based system often magnifies structural weaknesses. Larger footprints still compete for the same out-of-pocket consumer. Expanded delivery networks still rely on the same price-driven acquisition tactics. Without structural changes to how medical cannabis is accessed and financed, scale alone does not change the underlying economics. Health care markets behave differently. When therapies are integrated into benefit systems, demand stabilizes. Patient access is mediated through structured pipelines rather than retail foot traffic. Benefits and reimbursement frameworks encourage continuity of care. Claims systems normalize repeat engagement. Price sensitivity shifts when costs are partially offset through employer-sponsored or insurer-backed benefit programs. That infrastructure—not simply federal rescheduling—is what distinguishes a retail market from a health care-adjacent one. To be clear, rescheduling could create downstream opportunities for research expansion, physician comfort and broader regulatory clarity. Those developments may gradually influence payer behavior. But none of them automatically generate reimbursement and benefit mechanisms. Without deliberate policy movement toward benefit integration, cannabis will remain caught between two identities: treated as medicine by patients, but treated as a consumer good by federal health systems. This liminal status creates volatility. Operators continue to navigate compressed margins, price competition and retention challenges not solely because of tax burdens, but because medical cannabis lacks the institutional support systems that anchor other therapeutic categories. In most states, medical programs operate independently from federal health care frameworks. Employers that choose to support medical cannabis reimbursement do so through patchwork arrangements rather than standardized guidance. Payers face ambiguity about compliance, coding and risk exposure—and delay their entry. Rescheduling does not resolve that ambiguity. If policymakers intend for cannabis to evolve into a health care-adjacent market, reform cannot stop at tax relief. Clear federal guidance on reimbursement pathways, claims administration and benefit integration would do more to stabilize long-term demand than scale-driven consolidation alone. Otherwise, the industry risks a familiar cycle: regulatory optimism, acquisition waves, margin pressure and retrenchment. Rescheduling may reduce friction. But without reimbursement reform, it does not redesign the system to meet the needs of patients dependent on these valuable therapeutics. A stable cannabis industry requires more than tax normalization. It requires integration into healthcare infrastructure that governs how therapeutic products are accessed, financed and sustained. Until the stage is set for such integration, consolidation will expand footprints—but won’t strengthen foundations. Gennaro Luce is the CEO of CannaLnx by EM2P2, the first HIPAA-compliant digital platform that connects patients, doctors, dispensaries and healthcare payers. Matthew Myro Rothman is the company’s Chief Science Officer. The post Trump’s Cannabis Rescheduling Move Alone Won’t Stabilize The Industry Without Insurance Reimbursement Reform (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

122. Microdosing for Midlife: Stability & Nervous System Change (Week 5) Week 5 explores masking, authenticity, the Default Mode Network, and how microdosing may soften rigid self-narratives in midlife. Episode Summary This episode is part Week 5 of Microdosing for Midlife—a 12-part audio companion to the original Substack series. In this conversation, April explores authenticity not as a dramatic revelation, but as a gradual unmasking. Rather than chasing peak experiences or forced breakthroughs, she reflects on how microdosing intersects with identity, ego softening, and the quiet recognition of truths long postponed. The episode examines the difference between escape and exposure—and why midlife often demands something more sustainable than either. Drawing from neuroscience, lived experience, and even a bridge to quantum physics, April considers how the Default Mode Network (DMN) reinforces self-stories—and how gentle disruptions may create space for new ones. This is not about dramatic ego dissolution. It’s about noticing the yes that’s actually a no, the roles we’ve outgrown, and the parts of ourselves we’ve hidden to stay acceptable. If you’ve read the original essay, this episode deepens it. If you haven’t, it stands on its own—and may send you back to read more closely. Key Takeaways How “masking” functions psychologically and neurologically The role of the Default Mode Network in identity and self-story Why escape and authenticity are often confused How microdosing may soften rigid self-narratives The difference between forced revelation and sustained alignment What flow actually represents in midlife transition One reflection to carry into the week ahead Timestamps [00:00] Episode opening[02:00] Masking, escape, and authenticity[05:00] A personal mask-off moment[07:00] Default Mode Network and ego narratives[10:00] Observation and identity[13:00] Flow and sustained alignment[15:00] What to carry forward Resources Micro-Psyched 12-Week Microdosing Program Upcoming Psychedelic Salon tickets Follow April on Substack Original Microdosing for Midlife Substack post: https://aprilpride.substack.com/p/microdosing-for-authenticity Hosted by April Pride @aprilpride_ Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@getsetset⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@getsetset⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@getsetset Get full access to SetSet with April Pride at aprilpride.substack.com/subscribeCatch the full episode here

Connecticut lawmakers have approved a bill to expand a pilot program in the state that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. Members of the legislature’s Joint Committee on Public Health on Tuesday favorably reported the psychedelics measure, which would build upon an existing psychedelic-assisted therapy program involving military veterans and first responders who elect to participate in clinical trials. The new legislation would repeal and replace the current statute to make it so any adults 18 or older who meet clinical eligibility criteria established by the institutional review board of the medical school selected to administer the pilot program could be eligible to receive psychedelics treatment in a clinical setting, with researchers tasked with studying the efficacy of the novel therapeutics. It would also remove existing language stipulating that the pilot program must end upon federal approval of psilocybin or MDMA by the Drug Enforcement Administration (DEA) or a successor agency. Additionally, the bill—which has been transmitted to the non-partisan Legislative Commissioners’ Office for analysis—would strike dated language requiring the state Department of Mental Health and Addiction Services to create and facilitate the program by January 2023. Under the proposal, SB 191, the department is mandated to “establish, within available appropriations, a psychedelic-assisted therapy pilot program, to be administered by a medical school in the state.” That program “shall provide qualified patients with MDMA-assisted or psilocybin-assisted therapy as part of a research program approved by the federal Food and Drug Administration,” or FDA. “There’s a chance that psychedelic medications for this purpose will be approved by the FDA, which makes the research study stop if you don’t make a change in the language,” Sen. Saud Anwar (D), chair of the Public Health Committee, said. “So that’s the main purpose of this.” The rationale behind the initial bill that created the pilot program “was that veterans were committing suicide on a very frequent basis, even in our state,” he said, “and initial data had shown that we could save their lives. That was the reason that we were able to put some resources to save as many lives as we could, because the FDA process is slow.” “This has the FDA-based criteria for the study, but it’s not an FDA study, and we do not suggest—as a body, as a public health committee—that we wanted to go outside of the FDA guidelines,” Anwar aid. “It’s not FDA-approved at this time. But should that happen, we do not want to have anybody have a negative outcome.” The senator added that the legislation’s criteria for inclusion in the psychedelics pilot program was expanded beyond veterans and first responders in response to a “request made by the clinicians and the researchers.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, last year, the full House of Representatives approved a bill to decriminalize psilocybin for adults—despite questions about whether the state’s Democratic governor would support it after he rejected an earlier version of the reform measure. That marked the third session in a row that Connecticut lawmakers worked to advance psilocybin decriminalization. In 2023, the reform measure cleared the House but did not move through the Senate. The Judiciary Committee also approved a version in 2024. Gov. Ned Lamont (D) also signed a large-scale budget bill in 2022 that included provisions to set the state up to provide certain patients with access to psychedelic-assisted treatment using substances like MDMA and psilocybin. Separately, Connecticut lawmakers are also among the latest in the U.S. to take up legislation this session to allow medical marijuana use by certain qualifying patients at health facilities such as hospitals, nursing homes and hospices. Image courtesy of CostaPPR. The post Connecticut Lawmakers Approve Bill To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The governor of Wisconsin is calling on congressional lawmakers to urgently take action to block a federal hemp THC ban that threatens to wipe out much of the state’s cannabis market—an issue he says is “intensified” by the fact that the state has yet to legalize marijuana for medical or adult use. In a letter sent to Wisconsin’s congressional delegation on Tuesday, Gov. Tony Evers (D) warned about the ramifications of the pending federal hemp policy change that’s set to take effect in November under a large-scale bill President Donald Trump signed into law last year. He said without “legislative modification,” the new law “will have significant implications for Wisconsin hemp farmers, processors, retailers, and our broader economy.” “Hemp-derived products currently support a growing sector of legitimate businesses across Wisconsin, employing nearly 3,500 employees and contributing meaningfully to local economies with over $700 million in economic production,” the governor wrote, adding that the hemp policy change means “many of these existing lawful products would be reclassified in a manner that effectively eliminates existing business models, forcing closures, layoffs, and lost investment.” Evers is far from alone in his call for action. Industry stakeholders and legislators across the aisle have insisted that the federal reclassification of hemp would effectively eliminate the market that’s evolved since the crop and its derivatives were federally legalized under the 2018 Farm Bill. At minimum, they’ve called for an extended implementation delay so there’s more time to consider alternatives to outright recriminalization. “The growing of hemp has become a strong diversification option for Wisconsin farmers, and as of November 2025, Wisconsin had 470 federally licensed hemp producers. Regulatory uncertainty surrounding the definition of hemp undermines their ability to plan responsibly and threatens to disrupt crop selection, with the potential to leave fields sitting idle for the 2026 season and beyond,” the letter says. “Without timely federal legislative action, Wisconsin producers may be forced to abandon hemp cultivation altogether, resulting in lost income and diminished economic opportunities, especially in our rural communities.” “Our farmers already deal with enough, and the constant chaos and confusion out of D.C. caused by reckless trade wars and erratic tariff taxes continues to make an already strenuous job even harder,” it continues. “State and federal leadership must not turn its back on the farming communities and families who have long been, and always will be, the bedrock of our nation’s continued success.” Notably, Evers said that the impacts of the forthcoming hemp policy change are “further intensified by the fact that Wisconsin has not enacted legislation legalizing medical or recreational marijuana, despite multiple attempts by my administration to do so.” The governor has repeatedly pushed for the reform— including legalization in multiple budget requests, for example—but efforts to enact the reform have consistently stalled out even as adult-use markets have come online in neighboring states such as Illinois and Michigan. “While consumer demand for hemp-derived products remains strong, the absence of a legalized marijuana market in Wisconsin means that many of these products serve as lawful alternatives for Wisconsinites and an important source of revenue for instate businesses,” Evers said. “Restrictive changes to the hemp definition will only drive commerce for hemp-derived products across state lines, shifting jobs and tax revenue away from Wisconsin.” A Wisconsin Senate committee last month approved a bill to legalize medical marijuana in the state as other legislators push for broader adult-use legalization. The state’s Republican-controlled Senate and Assembly last year rejected an attempt to legalize cannabis, defeating amendments to budget legislation that would have ended prohibition and established new medical and recreational cannabis programs. Evers is not seeking re-election. But he said last year that if his party can take control of the legislature, the state can “finally” legalize marijuana so that residents don’t have to go to neighboring Illinois to visit its adult-use market. “Due to the unique situation Wisconsin is left in, outlined above, I strongly believe federal legislation is needed to prevent the negative impacts of the new federal hemp definition,” he said, while urging lawmakers to support a bipartisan bill to delay the implementation of the policy change for two years to give the industry time to consider regulatory alternatives. “This is about preserving lawful agricultural production that supports our local farmers and producers, protecting small businesses, and ensuring regulatory clarity for an industry that Congress itself created through prior legislation,” he said. “Time is of the essence. Farmers, producers, and retailers need certainty now in order to make informed decisions for the 2026 growing season and beyond. I urge you to act promptly to protect Wisconsin’s agricultural producers, small businesses, and workforce.” On the other side of the debate, a coalition of law enforcement and anti-drug groups recently called on congressional leaders to oppose efforts to delay the implementation of the hemp THC ban. As certain lawmakers seek to push back the implementation timeline—with delays included in proposed amendments for the latest Farm Bill that’s being marked up in a key House committee on Tuesday, for example—the prohibitionists groups led by Community Anti-Drug Coalitions of America (CADCA) are sounding the alarm. One 2026 Farm Bill amendment to delay the hemp ban would only extend the timeline by another year, and another would delay it for two years, though those proposals are expected to be killed given that the House committee chairman has claimed they are not germane to the underlying bill. A separate standalone bill from the amendment sponsor, Rep. Jim Baird (R-ID), would give the industry two additional years to consider regulatory alternatives to an outright ban. Hemp and alcohol industry stakeholders are on full alert amid a pending ban on hemp THC products—including increasingly popular cannabinoid beverages—and a former Democratic congressman who owns a major alcohol company recently spoke at Wine & Spirits Wholesalers of America’s (WSWA) Access LIVE 2026 event in Las Vegas where he and others discussed the policy landscape around hemp and how to avert an industry-wide upheaval. WSWA, which hosted the event, has been closely monitoring federal hemp policy developments, and the association was among the first in the sector to call on Congress to dial back language in the now-enacted law set to ban most consumable hemp products, while proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Other major alcohol retailers came together in January to encourage Congress to delay the enactment of the law Trump signed that will federally recriminalize hemp-derived THC beverages and other products. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis. The provisions set to take effect later this year specify that, within one year of enactment, the weight will apply to total THC—including delta-8 and other isomers. It will also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).” The new definition of legal hemp will additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it. Legal hemp products will be limited to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects. Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies were supposed to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other known cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” However, FDA appears to have missed that deadline. A spokesperson told Marijuana Moment last month that the lists would be posted in the Federal Register when they’re available. Lawmakers from across the aisle have been raising concerns about the potential consequences of the hemp redefinition, which would eradicate most consumable cannabinoid products that have become commonplace in states across the U.S., including those where marijuana hasn’t been legalized. Rep. James Comer (R-KY) and Kentucky Agriculture Commissioner Jonathan Shell are among the critics of the ban, and they sent a letter to Sen. Mitch McConnell (R-KY) last month imploring him to use his influence to avert the recriminalization, at least on a temporary basis, by supporting the proposed implementation delay. While McConnell championed hemp legalization under the 2018 Farm Bill, however, the former Senate majority leader has supported unraveling the hemp THC market that he’s described as an unintended consequences of the broader agriculture legislation. The post Wisconsin Governor Pushes To Stop Federal Hemp THC Ban, Saying Lack Of Legal Marijuana In State Makes The Impacts ‘Intensified’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Washington State Senate committee has approved a House-passed bill to allow terminally ill patients to use medical cannabis in healthcare facilities such as hospitals, nursing homes and hospices. The legislation, sponsored by Rep. Shelley Kloba (D), cleared the Senate Ways & Means Committee on Monday after having previously been passed by the full House of Representatives in a vote of 89-6 last month and later advanced by the Senate Health & Long-Term Care Committee. If enacted in to law, it would mandate that hospitals and other specified healthcare facilities allow terminally ill patients to use medical marijuana on the premises beginning on January 1, 2027, subject to certain rules and restrictions. “The medical use of cannabis may support improved quality of life for a qualifying patient…with a terminal condition,” the bill’s text says. “It is the intent of the legislature to promote dignity and comfort for terminally ill patients while maintaining the integrity and safety of health care environments.” Under HB 2152, patients and their caregivers would be responsible for acquiring and administering medical marijuana, and it would need to be stored securely at all times in a locked container. Smoking or vaping of cannabis would be prohibited, so patients would need to consume it via other methods. Marijuana could not be shared between patients and visitors, and the right to use medical cannabis under the bill would not apply to patients who are in the emergency department. Healthcare facility officials would need to see a copy of patients’ authorization to use medical cannabis, and they would be required to note their use of the drug in medical records. They would also need to establish a formal policy “allowing for the medical use of cannabis” on the premises. Facilities would also be able to suspend permission to use cannabis under the bill if a federal agency such as the U.S. Department of Justice or Centers for Medicare and Medicaid Services takes an enforcement action against such use or “issues a rule or other notification that expressly prohibits the medical use of cannabis in health care facilities.” The House Health Care & Wellness Committee adopted an amendment to exempt nursing homes operated by a residential habilitation center from the requirement to allow the medical use of cannabis, to clarify that the bill doesn’t apply to patients who haven’t been formally admitted to a hospital and to specify that patients and their caregivers are responsible for retrieving the medical cannabis (in addition to their responsibilities related to acquiring, administering, and removing the medical cannabis). The bill next heads to the Senate Rules Committee and then the floor before potentially being sent to the desk of Gov. Bob Ferguson (D). — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Lawmakers in several other states are also considering and advancing bills to expand medical marijuana access in hospitals, nursing homes and hospices. California and a handful of other states already have laws allowing terminally ill patients to use medical cannabis in healthcare facilities. Known as “Ryan’s Law,” the legislation is partly inspired by the experience of Jim Bartell, whose son died from cancer and was initially denied access to cannabis at a California hospital. The Bartells did eventually find a facility that agreed to allow the treatment, and Jim said Ryan’s quality of life improved dramatically in his final days. “In the invaluable last days as Ryan fought stage 4 pancreatic cancer, I first-handedly experienced the positive impact medical cannabis had on my son’s well-being, as opposed to the harsh effects of opiates,” Bartell said in 2021 when California’s governor signed Ryan’s Law. “Medical cannabis is an excellent option for relieving pain and suffering in those who are terminally-ill, but most importantly it serves to provide compassion, support, and dignity to patients and their families, during their loved-ones’ final days.” “Looking at each other, holding Ryan’s hand and telling him how much I loved him during his final moments would not have been possible without the medical cannabis,” he said. Meanwhile, Washington State lawmakers this session also filed a bill to legalize the home cultivation of marijuana for personal use by adults. Separate legislation was also introduced to allow short-term rentals like Airbnbs in Washington State would be able to offer guests complimentary marijuana prerolls. Yet another measure that was filed would legalize and regulate therapeutic use of the psychedelic psilocybin. The post Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Massachusetts voters will have a chance to vote on a ballot initiative in November that would roll back the state’s adult-use marijuana law—and a new poll shows that an overwhelming majority of residents do not want to see that happen. The Bay State Poll from the University of Hampshire’s States of Opinion Project asked Massachusetts adults about six separate ballot proposals that could go before voters at the upcoming election, including one that would repeal state law permitting recreational cannabis sales and the cultivation of marijuana for personal use. Nearly 2 in 3 Bay Staters (63 percent) said they’re opposed to the marijuana measure, including 48 percent who said they’re “strongly” opposed. Just 20 percent of respondents said they’re in favor of the proposed initiative, with 11 percent “strongly” supportive of the repeal. Opposition was strongest among Democrats, at 73 percent, followed by independents (69 percent) and a plurality of Republicans (42 percent) Support for the cannabis repeal initiative was the lowest of any of the six ballot questions that responders were asked about, which also included proposals to allow same-day voter registration, lowering the state income tax, establishing rent control laws and more. The survey—which involved interviews with 670 Massachusetts residents from February 12-16, with a +/-3.8 percentage point margin of error—comes months after cannabis activists filed a complaint with the State Ballot Law Commission under the Secretary of State’s office, alleging that petitioners with the anti-cannabis campaign used misleading tactics to convince voters to support its ballot placement. The commission rejected the complaint in January, however, and said advocates who challenged the ballot measure raised “unsupported allegations” about the propriety of the signature gathering process that they said warranted official scrutiny. That decision represented a setback for advocates and industry stakeholders who have flagged numerous accounts of alleged misconduct by petitioners working on behalf of the Coalition for a Healthy Massachusetts. It also came as separate polling found that nearly half of those who signed the marijuana sales repeal petition felt misled, with many claiming that the measure was pitched to them as a proposal to address unrelated issues such as public education and expanded housing. The anti-marijuana coalition has denied any wrongdoing in the signature collection process and waved off the survey results. The initiative would still let adults 21 and older possess and gift up to an ounce of cannabis, but it would repeal provisions of the voter-approved legalization law allowing for commercial sales and home cultivation by adults. The medical cannabis program would remain intact under the measure. An association of state marijuana businesses had separately urged voters to report to local officials if they observe any instances of “fraudulent message” or other deceitful petitioning tactics. Massachusetts Attorney General Andrea Campbell’s (D) office—which cleared the campaign for signature gathering in September—has stressed to voters the importance of reading the summary, which is required to go at the top of the signature form, before signing any petitions. The Massachusetts legislature received the initiative for consideration earlier this month when the 2026 session kicked off. Now that the state election commission has issued its ruling on the complaint, lawmakers have until May 5 to act on the proposal. If they choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot. Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs. To that point, Massachusetts recently reached another marijuana milestone, with officials announcing last month that the state has surpassed $9 billion in adult-use cannabis purchases since the market launched in 2018. Meanwhile, Massachusetts lawmakers recently assembled a bicameral conference committee to reach a deal on a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. In December, state regulators also finalized rules for marijuana social consumption loungues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — CCC recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry. State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments. Also in Massachusetts, legislators who were working on a state budget butted heads with CCC officials, who’ve said they can’t make critical technology improvements without more money from the legislature. Massachusetts lawmakers additionally approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics. And two committees have separately held hearings to discuss additional psilocybin-related measures. The post Massachusetts Ballot Measure To Roll Back Marijuana Legalization Is Opposed By Most State Residents, Poll Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Hemp THC ban pro & con arguments to Congress; MD medical marijuana employment protections; VA cannabis resentencing votes Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The U.S. Supreme Court heard oral arguments in a case on marijuana consumers’ Second Amendment gun rights, with most justices appearing skeptical of the Trump administration’s defense of the ban—and some suggesting a pending rescheduling action undermines the idea that cannabis consumption makes a person uniquely dangerous and subject to disarmament. The lawyer representing the Trump Department of Justice told justices, however, that “the government has not made final decisions with respect to what to do with marijuana” rescheduling yet. Former Rep. David Trone (D-MD), who owns Total Wine & More, expressed concerns about the looming federal recriminalization of hemp THC products in an appearance at a Wine & Spirits Wholesalers of America event. “This is now an adult beverage category, whether it’s a beer tonight or a glass of wine or an adult hemp beverage.” The Virginia House and Senate Courts of Justice Committees amended and approved bills to provide resentencing relief for people with prior marijuana convictions, setting the stage for bicameral negotiations as separate legislation to legalize recreational cannabis sales also advances. The Maryland Senate Finance Committee approved a bill to protect firefighters and rescue workers from being penalized for off-duty use of medical cannabis, with the sponsor saying marijuana provides a “safer, viable alternative” to opioids. Law enforcement and anti-drug groups sent a letter urging congressional leaders not to delay the federal recriminalization of hemp THC products from taking effect with a new Farm Bill being marked up this week. The Missouri Division of Cannabis Regulation filed proposed rule changes to target bad actors in the industry, streamline ownership changes, allow publicly traded companies to own cannabis licenses and establish product recall procedures. / FEDERAL The Department of Defense inspector general reportedly stalled a review into the Trump administration’s deadly military strikes on suspected drug boats. The Drug Enforcement Administration promoted an article about a study that found teens who use marijuana are “twice as likely to develop psychotic or bipolar disorders.” Rep. Dave Joyce (R-OH) discussed his support for cannabis law reform. / STATES Indiana Gov. Mike Braun (R) deflected a question about marijuana reform to lawmakers. The Omaha Tribe of Nebraska’s attorney general discussed plans to move forward with a medical cannabis program despite pushback from state officials. The Iowa House Economic Growth and Technology Committee approved a bill to classify hemp as an agricultural commodity. The Oregon House Committee on Economic Development, Small Business, and Trade rejected a bill to enact new restrictions on cannabis edibles. Illinois marijuana and hemp bills advanced to the Senate Cannabis Committee. Here’s a look at where North Carolina legislature candidates stand on legalizing medical cannabis. California regulators are moving to change rules on multipack cannabis goods. Washington State regulators published an updated list of pesticides allowed in the production of marijuana. Michigan regulators filed a complaint against a marijuana business over alleged violations. Kentucky regulators are hosting a series of medical cannabis informational webinars. The New York Cannabis Control Board will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL A San Francisco, California supervisor is proposing legislation to ban retail sales of nitrous oxide. / INTERNATIONAL Ghana’s interior minister said the country’s launch of a medical cannabis program is “about job creation, medicine and revenue, not about recreational use of drugs.” / SCIENCE & HEALTH A review concluded that “CBD could be an effective pharmacological intervention to prevent the enlargement of the secondary wave of” traumatic brain injury. A review concluded that “cannabinoid-based therapies may reduce pain in some patients with diabetic peripheral neuropathy.” / ADVOCACY, OPINION & ANALYSIS The Wall Street Journal editorial board weighed in on the case on marijuana consumers’ gun rights that’s before the U.S. Supreme Court, saying, “to regain the Second Amendment’s protection, all they have to do is quit.” New York Times reporter Robert Draper wrote about his experiences using ibogaine and 5-MeO-DMT at a clinic in Mexico. / BUSINESS Tilray Brands, Inc. acquired BrewDog. The Cannabist Company Holdings Inc. announced that an ad hoc group of noteholders of its senior secured notes and senior secured convertible note agreed to a further extension and to forbear from exercising any of their rights and remedies under the amended and restated indenture. / CULTURE Paul McCartney discussed his 1980 arrest for marijuana in Japan in a new documentary. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Supreme Court talks cannabis rescheduling in gun rights hearing (Newsletter: March 3, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I found your this post while searching for information about blog-related research ... It's a good post .. keep posting and updating information. ufabet เข้าไม่ได้

I recently came across Gurgaon Escorts while searching for premium companionship options, and I must say the overall presentation looks very professional. The profiles appear well managed and detailed, which helps in making a comfortable choice. It is good to see services that focus on privacy and client satisfaction. Clear communication and transparency always make a difference in this industry. If someone is looking for a reliable and discreet experience in the city, this seems like a promising platform to explore further.

it was a wonderful chance to visit this kind of site and I am happy to know. thank you so much for giving us a chance to have this opportunity.. ufabet เว็บไหนดี

If you are looking for premium companionship that does not burn a hole in your pocket then our Jaipur Escorts Service is your best bet in the city. We believe that everyone deserves a taste of luxury and passion without breaking the bank. Our girls are handpicked from different backgrounds and they bring their unique charm and personality to every encounter. They are extremely friendly and cooperative and they will go out of their way to make sure you leave with a smile on your face. Contact us today to book a session with a stunning diva who knows how to treat a gentleman right.